Skip to content

HeRO Vascular Access Device Post Market Procedural Survey Protocol

HeRO Vascular Access Device Post Market Procedural Survey Protocol

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00889291
Acronym
PPS
Enrollment
77
Registered
2009-04-28
Start date
2008-12-31
Completion date
2009-01-31
Last updated
2017-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End Stage Renal Disease

Keywords

End stage renal disease, Bacteremia, HeRO Vascular Access Device, Access challenged, Catheter dependent, End stage renal disease requiring vascular access. See HeRO device instructions for use for appropriate patient population

Brief summary

Post market observational survey of a vascular access device for access-challenged patients. Data collection efforts focused on patient medical and access history and implant procedure results.

Detailed description

Evaluation Design: This is a multi-center post market observational survey designed to collect procedural data on a minimum of 50 HeRO™ patients in the commercialization phase. Data will be collected retrospectively for patients already implanted with the HeRO™ device in the commercialization phase or prospectively for patients that receive the HeRO™ Device during the data collection period. No special patient screening, testing, or procedures are required. There is no required patient follow-up. Subject Population: Any patients the investigator deems/deemed eligible for HeRO™ implant with complete procedural data are eligible for inclusion in this post market observational survey. Endpoints: None Inclusion/Exclusion Criteria: There are no formal screening criteria other than patients must have all required procedural data points available for recording on the case report form.

Interventions

None listed

Sponsors

Merit Medical Systems, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* None

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frame
Device placement successEnd of procedure

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026